| 1 |
Hagan T, Cortese M, Rouphael N, et al. Antibiotics-driven gut microbiome perturbation alters immunity to vaccines in humans[J]. Cell, 2019, 178(6):1313-1328.
|
| 2 |
Bäckhed F, Ley RE, Sonnenburg JL, et al. Host-bacterial mutualism in the human intestine[J]. Science, 2005, 307(5717):1915-1920.
|
| 3 |
O'Hara AM, Shanahan F. The gut flora as a forgotten organ[J]. EMBO Rep, 2006, 7(7):688-693.
|
| 4 |
Wang Z, Klipfell E, Bennett BJ, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease[J]. Nature, 2011, 472(7341):57-63.
|
| 5 |
Lavelle A, Sokol H. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease[J]. Nat Rev Gastroenterol Hepatol, 2020, 17(4):223-237.
|
| 6 |
Agus A, Clément K, Sokol H. Gut microbiota-derived metabolites as central regulators in metabolic disorders[J]. Gut, 2021, 70(6):1174-1182.
|
| 7 |
Horta-Baas G, Sandoval-Cabrera A, Romero-Figueroa MDS. Modification of gut microbiota in inflammatory arthritis: highlights and future challenges[J]. Curr Rheumatol Rep, 2021, 23(8):67.doi: 10.1007/s11926-021-01031-9.
|
| 8 |
Pires A O, Mendes Pinheiro B, Teixeira F G, et al. Unveiling the differences of secretome of human bone marrow mesenchymal stem cells, adipose tissue-derived stem cells, and human umbilical cord perivascular cells: a proteomic analysis[J]. Stem Cells Dev, 2016, 25(14):1073-1083.
|
| 9 |
Naji A, Eitoku M, Favier B, et al. Biologicalfunctions of mesenchymal stem cells and clinical implications[J]. Cell Mol Life Sci, 2019, 76(17): 3323-3348.
|
| 10 |
Chen Y, Yu Q, Hu Y, et al. Current research and use of mesenchymal stem cells in the therapy of autoimmune diseases[J]. Curr Stem Cell Res Ther, 2019, 14(7):579-582.
|
| 11 |
Pixley J S. Mesenchymal stem cells to treat type 1 diabetes[J]. Biochim Biophys Acta Mol Basis Dis, 2020, 1866(4):165315.doi: 10.1016/j.bbadis.2018.10.033.
|
| 12 |
Zhao L, Chen S, Yang P, et al. The role of mesenchymal stem cells in hematopoietic stem cell transplantation: prevention and treatment of graft-versus-host disease[J]. Stem Cell Res Ther, 2019, 10(1):182.doi: 10.1186/s13287-019-1287-9.
|
| 13 |
郭风宜，杨潇，高天舒. 肠道菌群在自身免疫性疾病中的研究进展[J]. 国际免疫学杂志, 2021, 44(1):91-96.
|
| 14 |
Morrison DJ, Preston T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism[J]. Gut Microbes, 2016, 7(3):189-200.
|
| 15 |
Rooks MG, Garrett WS. Gut microbiota, metabolites and host immunity[J]. Nat Rev Immunol, 2016, 16(6):341-352.
|
| 16 |
Maslowski K M, Vieira A T, Ng A, et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43[J]. Nature, 2009, 461(7268):1282-1286.
|
| 17 |
Singh N, Gurav A, Sivaprakasam S, et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis[J]. Immunity, 2014, 40(1): 128-139.
|
| 18 |
Thorburn AN, Mckenzie CI, Shen S, et al. Evidence that asthma is a developmental origin disease influenced by maternal diet and bacterial metabolites[J]. Nat Commun, 2015, 6:7320.doi: 10.1038/ncomms8320.
|
| 19 |
Smith PM, Howitt MR, Panikov N, et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis[J]. Science, 2013, 341(6145):569-573.
|
| 20 |
Ren Y, Su S, Liu X, et al. Microbiota-derived short-chain fatty acids promote bmp signaling by inhibiting histone deacetylation and contribute to dentinogenic differentiation in murine incisor regeneration[J]. Stem Cells Dev, 2020, 29(18):1201-1214.
|
| 21 |
Iván J, Major E, Sipos A, et al. The short-chain fatty acid propionate inhibits adipogenic differentiation of human chorion-derived mesenchymal stem cells through the free fatty acid receptor 2[J]. Stem Cells Dev, 2017, 26(23):1724-1733.
|
| 22 |
Kimura I, Ozawa K, Inoue D, et al. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43[J]. Nat Commun, 2013, 4:1829.doi: 10.1038/ncomms2852.
|
| 23 |
李欣欣，孟明耀，熊晶晶, 等. 肠道菌群相关代谢物丁酸的量效和时效对人脐带间充质干细胞增殖的影响[J]. 中国微生态学杂志, 2020, 32(1):11-16.
|
| 24 |
Killer M C, Nold P, Henkenius K, et al. Immunosuppressive capacity of mesenchymal stem cells correlates with metabolic activity and can be enhanced by valproic acid[J]. Stem Cell Res Ther, 2017, 8(1):100.doi: 10.1186/s13287-017-0553-y.
|
| 25 |
Saouaf SJ, Li B, Zhang G, et al. Deacetylase inhibition increases regulatory T cell function and decreases incidence and severity of collagen-induced arthritis[J]. Exp Mol Pathol, 2009, 87(2):99-104.
|
| 26 |
Tsai LK, Wang Z, Munasinghe J, et al. Mesenchymal stem cells primed with valproate and lithium robustly migrate to infarcted regions and facilitate recovery in a stroke model[J]. Stroke, 2011, 42(10):2932-2939.
|
| 27 |
Luo L, Chen Q, Yang L, et al. MSCs Therapy reverse the gut microbiota in hypoxia-induced pulmonary hypertension mice[J]. Front Physiol, 2021, 12:712139.doi: 10.3389/fphys.2021.712139.
|
| 28 |
Zhao LN, Ma SW, Xiao J, et al. Bone marrow mesenchymal stem cell therapy regulates gut microbiota to improve post-stroke neurological function recovery in rats[J]. World J Stem Cells, 2021, 13(12):1905-1917.
|
| 29 |
Schugar RC, Shih DM, Warrier M, et al. The TMAO-producing enzyme flavin-containing monooxygenase 3 regulates obesity and the beiging of white adipose tissue[J]. Cell Rep, 2017, 19(12):2451-2461.
|
| 30 |
Wang H, Rong X, Zhao G, et al. The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer[J]. Cell Metab, 2022, 34(4):581-594.
|
| 31 |
Lin H, Liu T, Li X, et al. The role of gut microbiota metabolite trimethylamine N-oxide in functional impairment of bone marrow mesenchymal stem cells in osteoporosis disease[J]. Ann Transl Med, 2020, 8(16):1009.doi: 10.21037/atm-20-5307.
|
| 32 |
Li Y, Shi G, Han Y, et al. Therapeutic potential of human umbilical cord mesenchymal stem cells on aortic atherosclerotic plaque in a high-fat diet rabbit model[J]. Stem Cell Res Ther, 2021, 12(1):407.doi: 10.1186/s13287-021-02490-8.
|
| 33 |
De Vos W M, Tilg H, Van Hul M, et al. Gut microbiome and health: mechanistic insights[J]. Gut, 2022, 71(5):1020-1032.
|
| 34 |
Wahlström A, Sayin SI, Marschall HU, et al. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism[J]. Cell Metab, 2016, 24(1):41-50.
|
| 35 |
Huang W, Ma K, Zhang J, et al. Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration[J]. Science, 2006, 312(5771):233-236.
|
| 36 |
Sawitza I, Kordes C, Götze S, et al. Bile acids induce hepatic differentiation of mesenchymal stem cells[J]. Sci Rep, 2015, 5:13320.doi: 10.1038/srep13320.
|
| 37 |
Cha BH, Jung MJ, Moon BK, et al. Administration of tauroursodeoxycholic acid enhances osteogenic differentiation of bone marrow-derived mesenchymal stem cells and bone regeneration[J]. Bone, 2016, 83:73-81. doi: 10.1016/j.bone.2015.10.011.
|
| 38 |
王丽群，庞日朝，胡晓敏, 等. 肠道菌群对色氨酸代谢的影响研究进展[J]. 中国比较医学杂志, 2021, 31(4):129-136.
|
| 39 |
Borghi M, Puccetti M, Pariano M, et al. Tryptophan as a central hub for host/microbial symbiosis[J]. Int J Tryptophan Res, 2020, 13:1178646920919755. doi: 10.1177/1178646920919755.
|
| 40 |
Bosi A, Banfi D, Bistoletti M, et al. Tryptophan metabolites along the microbiota-gut-brain axis: an interkingdom communication system influencing the gut in health and disease[J]. Int J Tryptophan Res, 2020, 13:1178646920928984.doi: 10.1177/1178646920928984.
|
| 41 |
Comai S, Bertazzo A, Brughera M, et al. Tryptophan in health and disease[J]. Adv Clin Chem, 2020, 95:165-218.
|
| 42 |
Li X, Lu C, Fan D, et al. Human umbilical mesenchymal stem cells display therapeutic potential in rheumatoid arthritis by regulating interactions between immunity and gut microbiota via the aryl hydrocarbon receptor[J]. Front Cell Dev Biol, 2020, 8:131.doi: 10.3389/fcell.2020.00131.
|
| 43 |
王祖斌，朱一麟. hUC-MSCs治疗对免疫性血小板减少症患儿的免疫功能、色氨酸代谢通路以及相关基因表达的影响[J]. 海南医学院学报, 2016, 22(2):193-196.
|
| 44 |
Lu GM, Jiang LY, Huang DL, et al. Advanced platelet-rich fibrin extract treatment promotes the proliferation and differentiation of human adipose-derived mesenchymal stem cells through activation of tryptophan metabolism[J]. Curr Stem Cell Res Ther, 2021. doi: 10.2174/1574888X16666211206150934.
|
| 45 |
Henrick BM, Rodriguez L,Lakshmikanth T, et al. Bifidobacteria-mediated immune system imprinting early in life[J]. Cell, 2021, 184(15):3884-3898.e11.
|
| 46 |
Xing J, Ying Y, Mao C, et al. Hypoxia induces senescence of bone marrow mesenchymal stem cells via altered gut microbiota[J]. Nat Commun, 2018, 9(1):2020.doi: 10.1038/s41467-018-04453-9.
|
| 47 |
Sartori T, Santos ACA, Oliveira da Silva R, et al. Branched chain amino acids improve mesenchymal stem cell proliferation, reducing nuclear factor kappa B expression and modulating some inflammatory properties[J]. Nutrition, 2020, 78:110935.doi: 10.1016/j.nut.2020.110935.
|
| 48 |
Lee YS, Kim TY, Kim Y, et al. Microbiota-derived lactate promotes hematopoiesis and erythropoiesis by inducing stem cell factor production from leptin receptor+ niche cells[J]. Exp Mol Med, 2021, 53(9):1319-1331.
|
| 49 |
Suez J, Elinav E. The path towards microbiome-based metabolite treatment[J]. Nat Microbiol, 2017, 2:17075.doi: 10.1038/nmicrobiol.2017.75.
|